Investigation of the anxiolytic effects of naringenin, a component of mentha aquatica, in the male sprague-dawley rat

Holistic Nursing Practice

Volumn 26, Issue 1, 2012, Pages 52-57

  Anderson, Wesley ^a   Barrows, Mark ^a   Lopez, Fernando ^a   Rogers, Sara ^a   Ortiz Coffie, Adriana ^a   Norman, David ^a   Hodges, Jonathan ^a   McDonald, Keith ^a   Barnes, Devon ^a   McCall, Suzanne ^a   Johnson, Arthur Don ^a   Ceremuga, Thomas E ^a  

^a U S ARMY   (United States)

Author keywords

Anxiolysis; Elevated plus maze; Mentha aquatica; Mint; Naringenin; Sprague Dawley rat Holist Nurs Pract 2012; 26(1):52 57

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; FLAVANONE DERIVATIVE; NARINGENIN; PLANT EXTRACT;

ANIMAL; ANIMAL BEHAVIOR; ANXIETY; ARTICLE; BINDING SITE; CHEMISTRY; DRUG EFFECT; HERB DRUG INTERACTION; MALE; MAZE TEST; MENTHA; METABOLISM; MOTOR ACTIVITY; PHYTOTHERAPY; PROSPECTIVE STUDY; RANDOMIZATION; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; BENZODIAZEPINES; BINDING SITES; FLAVANONES; GAMMA-AMINOBUTYRIC ACID; HERB-DRUG INTERACTIONS; MALE; MAZE LEARNING; MENTHA; MOTOR ACTIVITY; PHYTOTHERAPY; PLANT EXTRACTS; PROSPECTIVE STUDIES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A;

EID: 84856868520     PISSN: 08879311     EISSN: 15505138     Source Type: Journal    
DOI: 10.1097/HNP.0b013e31823c003a     Document Type: Article

References (24)

1. Temple MD, Fagerlund K, Saewyc E. A national survey of certified registered nurse anesthetists' knowledge, beliefs, and assessment of herbal supplements in the anesthesia setting. Aana J. 2005;73(5): 368-377. (Pubitemid 41437376)
2. De Smet PA. Herbal remedies. N Engl JMed. 2002;347(25):2046-2056. (Pubitemid 35461662)
3. Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care. JAMA. 2001;286(2):208-216. (Pubitemid 32640852)
4. Brasfield K. Dietary supplement intake in the active duty enlisted population. US Army Med Dep J. 2004:44-56.
5. Food and Drug Administration. Dietary supplements. http://www.fda.gov/ food/dietarysupplements/default.htm. Accessed June 21, 2011.
6. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA. 1998;280(18):1569-1575. (Pubitemid 28520643)
7. Bovill JG. Adverse drug interactions in anesthesia. J Clin Anesth. 1997;9(6)(suppl):3S-13S.
8. Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet. 1993;342(8878):1007-1011. (Pubitemid 23314801)
9. Stafford GI, Pedersen ME, van Staden J, Jager AK. Review on plants with CNS-effects used in traditional South African medicine against mental diseases. J Ethnopharmacol. 2008;119(3):513-537.
10. Shi Y, Dai J, Liu H, et al. Naringenin inhibits allergen-induced airway inflammation and airway responsiveness and inhibits NF-kappaB activity in a murine model of asthma. Can J Physiol Pharmacol. 2009;87(9):729-735.
11. XiaX,Weng J. Targetingmetabolic syndrome: candidate natural agents. J Diabetes. 2010;2(4):243-249.
12. Lopez V, Martin S, Gomez-Serranillos MP, Carretero ME, Jager AK, Calvo MI. Neuroprotective and neurochemical properties of mint extracts. Phytother Res. 2010;24(6):869-874.
13. Stafford GI, Jager AK, van Staden J. Activity of traditional South African sedative and potentially CNS-acting plants in the GABAbenzodiazepine receptor assay. J Ethnopharmacol. 2005;100(1/2):210-215. (Pubitemid 41073548)
14. Surgeon General. Mental health: a report of the US surgeon general. Anxiety disorders. http://www.surgeongeneral.gov/library/mentalhealth/chapter4/ sec2.html. Accessed June 21, 2011.
15. Helpguide.org. Anxiety attacks and disorders: symptoms, types, and treatments. http://www.helpguide.org/mental/anxiety-types-symptoms-treatment. htm. Accessed June 21, 2011.
16. Selye H. Further thoughts on "stress without distress." Med Times. 1976;104(11):124-144.
17. KraftM. Holistic issues in the preoperative period. Int Anesthesiol Clin. Spring 2002;40(2):201-212. (Pubitemid 34275147)
18. Bauer KP, Dom PM, Ramirez AM, O'Flaherty JE. Preoperative intravenous midazolam: benefits beyond anxiolysis. J Clin Anesth. 2004;16(3):177-183. (Pubitemid 38813265)
19. Pellow S, Chopin P, File SE, Briley M. Validation of open-closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods. 1985;14(3):149-167. (Pubitemid 16239568)
20. Montgomery KC. The relation between fear induced by novel stimulation and exploratory behavior. J Comp Physiol Psychol. 1955;48(4):254-260.
21. Cayci C,Wahlquist TC, Seckin SI, et al. Naringenin inhibits neointimal hyperplasia following arterial reconstruction with interpositional vein graft. Ann Plast Surg. 2010;64(1):105-113.
22. Heese T, Jenkinson J, Love C, et al. Anxiolytic effects of Ltheanine, a component of green tea, when combined with midazolam, in the male Sprague-Dawley rat. AANA J. 2009;77(6): 445-449.
23. Leiter E, Hitchcock G, Godwin S, et al. Evaluation of the anxiolytic properties of myristicin, a component of nutmeg, in the male Sprague- Dawley rat. AANA J. 2011;79(2):109-114.
24. Miller RD. Miller's Anesthesia. 6th ed. New York, NY: Elsevier/ Churchill Livingstone; 2005.